Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDDate | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
05/13/2022 | Q1 2022 | -$1.75 | -$7.88 | -6.13 | $132,000 | |
03/17/2022 | Q4 2021 | -$1.57 | -$0.06 | 1.51 | $87,000 | |
11/10/2021 | Q3 2021 | -$2.68 | -$0.07 | 2.61 | $252,000 | |
08/10/2021 | Q2 2021 | -$2.68 | -$0.06 | 2.62 | $188,000 | |
05/12/2021 | Q1 2021 | -$2.68 | -$0.08 | 2.6 | $258,000 | |
03/11/2021 | Q4 2020 | -$3.32 | -$0.08 | 3.24 | $224,000 | |
11/13/2020 | Q3 2020 | -$3.38 | -$0.11 | 3.27 | $0 | |
08/06/2020 | Q2 2020 | -$4.90 | -$0.14 | 4.76 | $0 | |
05/14/2020 | Q1 2020 | -$8.87 | -$0.24 | 8.63 | $0 | |
03/12/2020 | Q4 2019 | -$0.47 | -$0.46 | 0.01 | $0 | |
11/14/2019 | Q3 2019 | -$0.58 | -$0.55 | 0.03 | $0 | |
08/14/2019 | Q2 2019 | -$0.56 | -$0.55 | 0.01 | $0 | |
05/14/2019 | Q1 2019 | -$0.78 | -$0.79 | -0.01 | $0 | |
03/25/2019 | Q4 2018 | -$0.85 | $0 | |||
11/15/2018 | Q3 2018 | -$0.68 | $0 | |||
08/09/2018 | Q2 2018 | -$0.89 | -$0.75 | 0.14 | $0 | |
05/15/2018 | Q1 2018 | -$4.16 | $0 | |||
03/12/2018 | Q4 2017 | -$4.80 | -$3.80 | 1 | $0 | |
11/09/2017 | Q3 2017 | -$3.60 | -$4.01 | -0.41 | $0 | |
08/10/2017 | Q2 2017 | -$3.80 | -$3.44 | 0.36 | $0 |
Zosano Pharma Corporation has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, May 13th, 2022 based off last year's report dates.
The conference call for Zosano Pharma Corporation's latest earnings report can be listened to online.
The conference call transcript for Zosano Pharma Corporation's latest earnings report can be read online.
Zosano Pharma Corporation (:ZSAN) has a recorded annual revenue of $785,000.
Zosano Pharma Corporation (:ZSAN) has a recorded net income of $785,000. Zosano Pharma Corporation has generated $-0.27 earnings per share over the last four quarters.
Zosano Pharma Corporation (:ZSAN) has a price-to-earnings ratio of -2.08 and price/earnings-to-growth ratio is -0.02.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED